• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
98% Bifida Ferment Lysate
rhSOD (cosmetic grade)
Recombinant humanized collagen
Recombinant Humanized Small-molecule Collagen
Recombinant Humanized Small-molecule Collagen Solution
rhSOD

Three-fold increase in remdesivir production in India: Mansukh Mandaviya

expresspharmaMay 07, 2021

Tag: Remdesivir , Mansukh Mandaviya , India

The production of remdesivir is being increased at a rapid pace in the country. In just a few days, India has achieved three times the production capacity of the medicine, and will soon be able to meet the growing demand, informed Mansukh Mandaviya, Minister of State for Chemical and Fertilizers via Twitter yesterday.

He also wrote, “In view of the increase in demand, the number of plants producing remdesivir has also gone up from 20 on 12th April, 2021 to 57 on 4th May, 2021.”

Further, the production has gone up from 37 lakh on 12th April, 2021 to 1.05 crore on 4th May, 2021, according to a statement by Ministry of Chemicals and Fertilizers.

Previous:RBI announces on-tap liquidity window of Rs 50,000 cr for healthcare infra, services firms

Next:MoHF&W issues guidelines for COVID-19 vaccine import by private sector

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Three-fold increase in remdesivir production in India: Mansukh Mandaviya | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

Remdesivir Intermediate

Remdesivir Intermediate
Remdesivir

Remdesivir
Evening Primrose Oil (OEM/ODM) | Evening Primrose Oil From India / natural Evening Prim rose Oil

Evening Primrose Oil (OEM/ODM) | Evening Primrose Oil From India / natural Evening Prim rose Oil

100% Pure Freeze Dried Black Berry Anthocyanin Juice Indian Instant Fruit Blackberry Powder

100% Pure Freeze Dried Black Berry Anthocyanin Juice Indian Instant Fruit Blackberry Powder
Remdesivir

Remdesivir
Remdesivir

Remdesivir
Remdesivir impurity 21

Remdesivir impurity 21
Factory Free Sample Bulk Food Pure Grade Natural India Herbal Plant Extract Madder Root Extract

Factory Free Sample Bulk Food Pure Grade Natural India Herbal Plant Extract Madder Root Extract
99% up by HPLC USP GMP DMF Remdesivir 1809249-37-3

99% up by HPLC USP GMP DMF Remdesivir 1809249-37-3
Remdesivir

Remdesivir

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service